Literature DB >> 16740603

Human Vgamma2Vdelta2 T cells contain cytoplasmic RANTES.

I Tikhonov1, C O Deetz, R Paca, S Berg, V Lukyanenko, J K Lim, C D Pauza.   

Abstract

The adult human Vgamma2Vdelta2 T cell repertoire is a product of chronic selection in the periphery. Endogenous antigens drive the expansion of cells expressing the Vgamma2Vdelta2 TCR. Thus, we would expect the majority of circulating Vgamma2Vdelta2 T cells to be antigen experienced and to have memory phenotype, in contrast to the alpha/beta TCR+ subsets that include a substantial fraction of naive cells. We sought to characterize functional aspects of Vgamma2Vdelta2 T cells that might show whether circulating cells are memory or naive. For these studies, we focus on the expression of the CC chemokine regulated upon activation normal T cell expressed and secreted (RANTES). In naive alphabeta T cells, an initial stimulus triggers the onset of RANTES transcription followed later by protein expression. In memory CD8+ alphabeta T cells, RANTES mRNA is already present in unstimulated cells and protein expression is triggered immediately by TCR signaling; some cells may also contain RANTES protein in cytoplasmic stores. We show here that the vast majority of circulating human T cells contain RANTES protein in cytoplasmic stores and the chemokine is secreted rapidly after TCR signaling. Primary Vgamma2Vdelta2 T cell lines obtained after in vitro stimulation with phosphoantigens behaved similarly to circulating Vgamma2Vdelta2 T cells and contained both RANTES mRNA and protein, but only very low levels of mRNA or protein for macrophage inflammatory protein (MIP)-1alpha or MIP-1beta. The presence of stored RANTES shows that circulating Vgamma2Vdelta2 T cells are mostly memory phenotype and capable of rapid chemokine responses to phosphoantigen stimulation. Considering that one of 40 circulating CD3+ lymphocytes is Vgamma2Vdelta2+, they comprise the largest circulating memory population against a single antigen, and phosphoantigen stimulation will trigger a rapid activation with immediate release of RANTES.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740603      PMCID: PMC2957085          DOI: 10.1093/intimm/dxl055

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  44 in total

1.  RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes.

Authors:  A Song; Y F Chen; K Thamatrakoln; T A Storm; A M Krensky
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

2.  CCR5 is characteristic of Th1 lymphocytes.

Authors:  P Loetscher; M Uguccioni; L Bordoli; M Baggiolini; B Moser; C Chizzolini; J M Dayer
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

Review 3.  Switching gears during T-cell maturation: RANTES and late transcription.

Authors:  B D Ortiz; P J Nelson; A M Krensky
Journal:  Immunol Today       Date:  1997-10

4.  Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins.

Authors:  S V Peña; D A Hanson; B A Carr; T J Goralski; A M Krensky
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

5.  Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB.

Authors:  V Groh; R Rhinehart; H Secrist; S Bauer; K H Grabstein; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

6.  Activation of dual T cell signaling pathways by the chemokine RANTES.

Authors:  K B Bacon; B A Premack; P Gardner; T J Schall
Journal:  Science       Date:  1995-09-22       Impact factor: 47.728

7.  Chemical synthesis and characterization of chemokine RANTES and its analogues.

Authors:  R A Boykins; T Oravecz; E Unsworth; C Syin
Journal:  Cytokine       Date:  1999-01       Impact factor: 3.861

8.  Natural and synthetic non-peptide antigens recognized by human gamma delta T cells.

Authors:  Y Tanaka; C T Morita; Y Tanaka; E Nieves; M B Brenner; B R Bloom
Journal:  Nature       Date:  1995-05-11       Impact factor: 49.962

9.  Crucial role of TCR gamma chain junctional region in prenyl pyrophosphate antigen recognition by gamma delta T cells.

Authors:  J F Bukowski; C T Morita; H Band; M B Brenner
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

10.  Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.

Authors:  R Bonecchi; G Bianchi; P P Bordignon; D D'Ambrosio; R Lang; A Borsatti; S Sozzani; P Allavena; P A Gray; A Mantovani; F Sinigaglia
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

View more
  16 in total

1.  Individual Vgamma2-Jgamma1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens.

Authors:  Andrew M Hebbeler; Cristiana Cairo; Jean Saville Cummings; C David Pauza
Journal:  Cancer Immunol Immunother       Date:  2006-11-28       Impact factor: 6.968

2.  Vgamma2Vdelta2 T Cell Receptor recognition of prenyl pyrophosphates is dependent on all CDRs.

Authors:  Hong Wang; Zhimei Fang; Craig T Morita
Journal:  J Immunol       Date:  2010-05-05       Impact factor: 5.422

3.  Impact of persistent HIV replication on CD4 negative Vγ2Vδ2 T cells.

Authors:  Sarah Boudová; Haishan Li; Mohammad M Sajadi; Robert R Redfield; C David Pauza
Journal:  J Infect Dis       Date:  2012-03-26       Impact factor: 5.226

4.  Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro.

Authors:  Haishan Li; C David Pauza
Journal:  Cancer Immunol Immunother       Date:  2010-11-25       Impact factor: 6.968

5.  Cardiolipin binds to CD1d and stimulates CD1d-restricted γδ T cells in the normal murine repertoire.

Authors:  Mélanie Dieudé; Harald Striegl; Aaron J Tyznik; Jing Wang; Samuel M Behar; Ciriaco A Piccirillo; Jerrold S Levine; Dirk M Zajonc; Joyce Rauch
Journal:  J Immunol       Date:  2011-03-09       Impact factor: 5.422

6.  Targeting γδ T cells for immunotherapy of HIV disease.

Authors:  C David Pauza; David J Riedel; Bruce L Gilliam; Robert R Redfield
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

Review 7.  Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications.

Authors:  Haishan Li; Suchita Chaudhry; Suchita Chaudry; Bhawna Poonia; Yiming Shao; C David Pauza
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

8.  TNF-alpha is a positive regulatory factor for human Vgamma2 Vdelta2 T cells.

Authors:  Haishan Li; Kun Luo; C David Pauza
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

9.  Association between Vgamma2Vdelta2 T cells and disease progression after infection with closely related strains of HIV in China.

Authors:  Haishan Li; Hong Peng; Pengfei Ma; Yuhua Ruan; Bing Su; Xinping Ding; Chen Xu; C David Pauza; Yiming Shao
Journal:  Clin Infect Dis       Date:  2008-05-01       Impact factor: 9.079

10.  Effects of 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and rosiglitazone on human gammadelta2 T cells.

Authors:  Haishan Li; C David Pauza
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.